Published in J Renin Angiotensin Aldosterone Syst on October 28, 2009
Aldosterone and mortality in hemodialysis patients: role of volume overload. PLoS One (2013) 0.83
Hypervolemia for hypertension pathophysiology: a population-based study. Biomed Res Int (2014) 0.75
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med (1999) 29.32
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med (2003) 13.25
Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2008) 6.48
Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med (1972) 4.80
The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant (2009) 3.08
Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension (2009) 2.99
Aldosterone in congestive heart failure. N Engl J Med (2001) 2.46
Predicting body cell mass with bioimpedance by using theoretical methods: a technological review. J Appl Physiol (1985) (1997) 2.28
Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci U S A (2003) 1.74
Importance of whole-body bioimpedance spectroscopy for the management of fluid balance. Blood Purif (2009) 1.66
Survival as an index of adequacy of dialysis. Kidney Int (1992) 1.66
Is it time for spironolactone therapy in dialysis patients? Nephrol Dial Transplant (2006) 1.53
The challenge of sudden death in dialysis patients. Clin J Am Soc Nephrol (2008) 1.52
Is spironolactone safe for dialysis patients? Nephrol Dial Transplant (2003) 1.51
Plasma aldosterone in hypertensive patients on chronic hemodialysis: distribution, determinants and impact on survival. Hypertens Res (2006) 1.43
Glycosaminoglycan polymerization may enable osmotically inactive Na+ storage in the skin. Am J Physiol Heart Circ Physiol (2004) 1.36
Osmotically inactive skin Na+ storage in rats. Am J Physiol Renal Physiol (2003) 1.36
Plasma aldosterone concentrations in chronic renal disease. Kidney Int (1982) 1.16
Bioimpedance, dry weight and blood pressure control: new methods and consequences. Curr Opin Nephrol Hypertens (2005) 1.11
Aldosterone and end-organ damage. Curr Opin Nephrol Hypertens (2005) 1.11
Long-term sodium balance in humans in a terrestrial space station simulation study. Am J Kidney Dis (2002) 1.07
Aldosterone-induced organ damage: plasma aldosterone level and inappropriate salt status. Hypertens Res (2004) 1.02
The extracellular fluid-to-intracellular fluid volume ratio is associated with large-artery structure and function in hemodialysis patients. Am J Kidney Dis (2003) 0.98
Volume control, blood pressure and cardiovascular function. Lessons from hemodialysis treatment. Nephron Physiol (2003) 0.98
Aldosterone-induced vasculopathy. Mol Cell Endocrinol (2004) 0.97
Current state of bioimpedance technologies in dialysis. Nephrol Dial Transplant (2008) 0.97
Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis. Am J Hypertens (1999) 0.95
Aldosterone and metabolic syndrome: is increased aldosterone in metabolic syndrome patients an additional risk factor? Hypertension (2008) 0.93
Hyporeninemia and hypoaldosteronism in diabetes mellitus. Arch Intern Med (1977) 0.89
Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients. Am J Kidney Dis (2005) 0.89
Regulation of plasma aldosterone concentration in anephric man and renal transplant recipients. Kidney Int (1973) 0.88
Modulation of plasma aldosterone concentration by plasma potassium in anephric man in the absence of a change in potassium balance. J Clin Invest (1973) 0.86
Safety of low-dose spironolactone administration in chronic haemodialysis patients. Nephrol Dial Transplant (2003) 0.83
Aldosterone in heart failure: pathophysiology and treatment. Curr Heart Fail Rep (2004) 0.82
Equivalence of information from single versus multiple frequency bioimpedance vector analysis in hemodialysis. Kidney Int (2005) 0.82
Application of bioimpedance techniques to peritoneal dialysis. Contrib Nephrol (2006) 0.81
Aldosterone blockade and vascular calcification in hemodialysis patients. Am J Med (2003) 0.81
Extracellular volume and aldosterone interaction in chronic kidney disease. Blood Purif (2009) 0.80
Aldosterone-receptor antagonism and end-stage renal disease. Curr Hypertens Rep (2004) 0.80
Bioimpedance analysis in dialysis: state of the art and what we can expect. Blood Purif (2009) 0.76
Use of segmental multifrequency bioimpedance spectroscopy in hemodialysis. Contrib Nephrol (2005) 0.76
Sugar-sweetened soda consumption, hyperuricemia, and kidney disease. Kidney Int (2009) 2.48
A simple algorithm to predict incident kidney disease. Arch Intern Med (2008) 2.36
Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J Am Soc Nephrol (2013) 2.06
Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review. Am J Kidney Dis (2008) 1.98
The incidence and implications of aldosterone breakthrough. Nat Clin Pract Nephrol (2007) 1.96
Periodontal disease adversely affects the survival of patients with end-stage renal disease. Kidney Int (2009) 1.74
Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med (2012) 1.64
Rituximab therapy for membranous nephropathy: a systematic review. Clin J Am Soc Nephrol (2009) 1.62
SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med (2007) 1.56
Differential risk of remission and ESRD in childhood FSGS. Pediatr Nephrol (2006) 1.53
Jack London's "chronic interstitial nephritis". A historical differential diagnosis. Pharos Alpha Omega Alpha Honor Med Soc (2008) 1.40
Changing patterns of anemia management in US hemodialysis patients. Am J Med (2012) 1.39
Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004). Am J Cardiol (2007) 1.23
High prevalence of sickle cell trait in African Americans with ESRD. J Am Soc Nephrol (2010) 1.23
Reproducibility of masked hypertension in adults with untreated borderline office blood pressure: comparison of ambulatory and home monitoring. Am J Hypertens (2010) 1.17
Memory and executive functions in pediatric chronic kidney disease. Child Neuropsychol (2006) 1.17
Lifestyle modifications to lower or control high blood pressure: is advice associated with action? The behavioral risk factor surveillance survey. J Clin Hypertens (Greenwich) (2008) 1.12
Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol (2012) 1.10
Kidney disease and the cumulative burden of life course socioeconomic conditions: the Atherosclerosis Risk in Communities (ARIC) study. Soc Sci Med (2008) 1.10
Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Kidney Int (2011) 1.09
Kidney disease in life-course socioeconomic context: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis (2007) 1.09
Chronic kidney disease and life course socioeconomic status: a review. Adv Chronic Kidney Dis (2005) 1.08
Hospitalization and skilled nursing care are predictors of influenza vaccination among patients on hemodialysis: evidence of confounding by frailty. Med Care (2013) 1.01
Gaining the PROMIS perspective from children with nephrotic syndrome: a Midwest pediatric nephrology consortium study. Health Qual Life Outcomes (2013) 0.96
Gaining the Patient Reported Outcomes Measurement Information System (PROMIS) perspective in chronic kidney disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol (2014) 0.94
Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int (2005) 0.91
The quality of cardiovascular disease care for adolescents with kidney disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol (2013) 0.90
A simple prediction score for kidney disease in the Korean population. Nephrology (Carlton) (2012) 0.89
Calcimimetics and the treatment of primary and secondary hyperparathyroidism. Ann Pharmacother (2004) 0.89
High prevalence of unlabeled chronic kidney disease among inpatients at a tertiary-care hospital. Am J Med Sci (2009) 0.89
Validation and comparison of a novel screening guideline for kidney disease: KEEPing SCORED. Arch Intern Med (2008) 0.89
Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience. Nephrol Dial Transplant (2009) 0.89
The differential effect of race among pediatric kidney transplant recipients with focal segmental glomerulosclerosis. Am J Kidney Dis (2004) 0.88
Renal transplantation in children with lupus nephritis. Am J Kidney Dis (2003) 0.88
Racial differences in kidney function among individuals with obesity and metabolic syndrome: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2010) 0.88
Health care transition for adolescents with CKD-the journey from pediatric to adult care. Adv Chronic Kidney Dis (2011) 0.88
Cognitive improvement in children with CKD after transplant. Pediatr Transplant (2010) 0.88
Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review. Am J Nephrol (2009) 0.87
Telemedicine and retinal imaging for improving diabetic retinopathy evaluation. Arch Intern Med (2012) 0.85
Severe lactic acidosis associated with juice of the mangosteen fruit Garcinia mangostana. Am J Kidney Dis (2008) 0.84
A randomized controlled trial of intensive periodontal therapy on metabolic and inflammatory markers in patients With ESRD: results of an exploratory study. Am J Kidney Dis (2012) 0.84
Normoalbuminuric diabetic kidney disease in the U.S. population. J Diabetes Complications (2012) 0.83
Risk of high dietary calcium for arterial calcification in older adults. Nutrients (2013) 0.82
Acute kidney injury in statin initiators. Pharmacoepidemiol Drug Saf (2013) 0.82
Comparative short-term safety of bolus versus maintenance iron dosing in hemodialysis patients: a replication study. BMC Nephrol (2014) 0.82
Psychosocial Factors and 30-Day Hospital Readmission among Individuals Receiving Maintenance Dialysis: A Prospective Study. Am J Nephrol (2017) 0.82
Renal aspirin: will all patients with chronic kidney disease one day take spironolactone? Nat Clin Pract Nephrol (2008) 0.81
Trends and variations in intravenous vitamin D use among hemodialysis patients in the United States. Ren Fail (2012) 0.81
Colonic necrosis due to sodium polystyrene sulfate (Kayexalate). Am J Emerg Med (2009) 0.81
Renal injury in extreme obesity: the important role of aldosterone. Kidney Int (2008) 0.81
Management of toxic ingestions with the use of renal replacement therapy. Pediatr Nephrol (2010) 0.80
Influenza and pneumococcal vaccination in dialysis patients: merely a shot in the arm? Am J Kidney Dis (2012) 0.80
Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose. J Am Soc Nephrol (2014) 0.80
Lifestyle modification advice for lowering or controlling high blood pressure: who's getting it? J Clin Hypertens (Greenwich) (2007) 0.79
Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients. Kidney Int (2011) 0.78
Systemic atherosclerosis and kidney disease. Arch Intern Med (2006) 0.78
Mineralocorticoid receptor blockade in chronic kidney disease. Curr Hypertens Rep (2011) 0.78
Mineralocorticoid receptor blockade in chronic kidney disease. Blood Purif (2012) 0.78
Pink urine after propofol anesthesia. Kidney Int (2010) 0.77
Nursing Intervention Aimed at Improving Self-Managementfor Persons with Chronic Kidney Disease in North Carolina Medicaid: A Pilot Project. Nephrol Nurs J (2015) 0.76
Sugar-sweetened beverage consumption and the progression of chronic kidney disease in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr (2009) 0.76
Aldosterone breakthrough during aliskiren, valsartan, and combination (aliskiren + valsartan) therapy. J Am Soc Hypertens (2012) 0.76
Back to the future: therapies for idiopathic nephrotic syndrome. Blood Purif (2015) 0.76
A measure of success in kidney transplantations. Pediatr Transplant (2004) 0.75
Pretransplantation erythropoiesis-stimulating agent hyporesponsiveness is associated with increased kidney allograft failure and mortality. Transplantation (2013) 0.75
Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: a reply. Nephrol Dial Transplant (2007) 0.75
The Case: Acute kidney injury in a patient with P. carinii pneumonia. Kidney Int (2009) 0.75
Lack of Knowledge and Low Readiness for Healthcare Transition in Eosinophilic Esophagitis and Eosinophilic Gastroenteritis. J Pediatr Gastroenterol Nutr (2016) 0.75
Gestational diabetes mellitus alone in the absence of subsequent diabetes is associated with microalbuminuria: results from the Kidney Early Evaluation Program (KEEP). Diabetes Care (2010) 0.75
Trends in Anemia Management in Hemodialysis Patients with Cancer. Am J Nephrol (2015) 0.75
A rare cause of the pulmonary-renal syndrome: a case of atypical haemolytic-uraemic syndrome complicated by pulmonary haemorrhage. NDT Plus (2008) 0.75
How can the safety and diagnostic yield of percutaneous renal biopsies be optimized? Nat Clin Pract Nephrol (2007) 0.75
Transition From Child to Adult Services: Current Research, Theory and Practice. J Pediatr Nurs (2015) 0.75
Jack London's "mysterious malady". Am J Med (2007) 0.75
Case-based education at the 2009 pediatric nephrology fellows conference. Ren Fail (2010) 0.75
Of snakes and men: the evolution of ACE inhibitors. J Renin Angiotensin Aldosterone Syst (2007) 0.75
Lack of Knowledge and Low Readiness for Health Care Transition in Eosinophilic Esophagitis and Eosinophilic Gastroenteritis. J Pediatr Gastroenterol Nutr (2017) 0.75
Preexisting crescentic glomerulonephritis in the renal allograft. Am J Kidney Dis (2003) 0.75